Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 452 results found. Search for [ coronavirus vaccine developed in India ]

Results 1 to 21 of 452
BusinessToday.In
November 30, 2020
PM Modi asks teams to come out with ideas on regulatory processes and related matters. As pharma companies move ahead with their clinical trials, the government has also stepped up efforts to devise the vaccine distribution plan


PTI
November 29, 2020
The legal notice has been sent to Pune based Serum Institute of India, which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, 'Covidshield.'


Chitranjan Kumar
November 29, 2020
Share market: Development on COVID-19 vaccine front, FII flow trends, RBI policy meet, auto sales numbers will set tone for Dalal Street next week


BusinessToday.In
November 29, 2020
India to develop vaccines for 60 percent of developing nations; 24 manufacturing units among 19 firms to develop vaccine in India: Bhargava


PTI
November 29, 2020
After making rounds everywhere in the world, the vaccine on COVID-19 would be found in Pune. Nothing is beyond Pune, the Baramati MP said


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


BusinessToday.In
November 29, 2020
Serum Institute of India's (SII) CEO Adar Poonawalla made the announcement hours after a meeting with Prime Minister Narendra Modi, who visited Serum's plant in Pune on Saturday, November 28


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


PTI
November 28, 2020
PM Modi landed at Hakimpet Air Force station near here at around 1 pm,as part of his three-city tour to take the stock of COVID-19 vaccine development


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


BusinessToday.In
November 26, 2020
SII has partnered with AstraZeneca and Oxford University for the manufacturing and distribution of its COVID-19 vaccine candidate 'Covishield' in India and other countries


BusinessToday.In
November 25, 2020
Indian drug regulator may provide an emergency approval to AstraZeneca's COVID-19 vaccine by end-December or early January 21, says Nomura


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


Joe C Mathew
November 24, 2020
In an open letter to Prime Minister Narendra Modi on November 24, the civil society representatives said the current incidence, prevalence, and fatality status of COVID-19 disease in India, do not call for such an approach


Joe C Mathew
November 24, 2020
The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country


BusinessToday.In
November 24, 2020
The researchers said they could not explicate why the half dose manifested better protection, but added it may be that it prompts the immune system differently


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


PAGES 1 OF 23  12345